chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a physician via call center representative and described the occurrence of varicella-like rash in a elderly patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included Parkinson's disease. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, several days after receiving SHINGRIX, the patient experienced varicella-like rash and blister. On an unknown date, the outcome of the varicella-like rash and blister were unknown. It was unknown if the reporter considered the varicella-like rash and blister to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had advanced Parkinson's disease. Five months before the date of reporting, the patient received SHINGRIX in the arm. The patient's wife noted that few days later that lower down on his arm, he developed pox like blisters in a semicircular arc small blisters about size of drop of water in a linear ring like arc a few inches below the injection site. The reporter asked whether the patient could get booster dose at the time of reporting or this reaction was contraindication.
Breakthrough case admission after 3 vaccines Moderna 3/4/21 Lot# 012L20A;  Moderna 3/31/21 Lot# 007M20A;  Moderna 12/1/21 Lot# 067F21
I started to have a lot of nasal congestion, coughing, and sneezing. These symptoms elevated really quickly. About a day of having symptoms, I took a COVID-19 test that came back negative.  The next day early in the morning on 8/8/2022 I took another COVID-19 test that came back positive.  I spoke with a Nurse and was advised to go to an urgent care facility. I went to an urgent care doctor, and they gave me a chest x-ray. I was prescribed a cough syrup and was given a referral to the COVID-19 clinic. They called me the next day, and I was given an oral medication. I took this medication for 5 days. My symptoms started to clear up after the first dose of medication. By the time I finished the 5-day treatment my symptoms had gone away.
Patient discharged after (3) day inpatient stay. 11/12-11/15/21.  Patient received booster Moderna vaccine 10/24/21. Previous doses were 2/10/21- lot # 029L20A  1/13/21- 026L20A  Patient is an 80-year-old male who was admitted on 11/12/2021 with acute hypoxia secondary to COVID-19 pneumonia.  Patient required 3 L and has been weaned down to 2 L. He was started on remdesivir and given 4 days worth but does not want to stay to finish 5 day course and choosing to go home.  Decadron was initiated and patient will continue this outpatient for full 10 days.     Patient also appeared to have acute exacerbation of his CHF he was started on a fluid restriction diet and given IV Lasix will transition back to his orally torsemide and Coreg regiment.  Patient declining PT/OT states he has this outpatient already established.  Patient will go home on oxygen with 2 L. Vitals are stable otherwise no further concerns patient is medically clear for discharge.   Last CRP done today 71.5 and D-dimer 1020 Normal liver function and kidney function is better today than baseline with a creatinine of 1.41 and GFR 48
Patient got Miller Fisher a variant of Guillain Barre 1-1-11. He has been healing since. It is very slow going.
started feeling different; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (started feeling different) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (started feeling different). At the time of the report, FEELING ABNORMAL (started feeling different) outcome was unknown.            No concomitant and treatment medications were reported.
Within 15 minutes of injection, patient became diaphoretic and dyspneic.  BP 210/120, P-87 steady, O2Sat-97-99.  Cold compresses applied and EMS notified.   2nd BP prior to EMS arrival was 160/135, O2Sat - 98.   Symptoms improved within 10-15 minutes.  EMS assessed patient and he was able to leave unassisted.
Got a small shingles lesion on my right cheek below my eye.  Lesion did not spread and went away in a few days. It was more like a shingles like breakthrough that didn?t develop into a full blown shingles outbreak. I have a photo of it if needed.   I have had shingles numerous times in the past, although not since I received the Shingrix vaccine a few years ago.
ON DAY 9- REDNESS ,SWELLING, AND HIVE AND ITCHY
Sore throat, legs aching, felt weak, headache, low-grade fever, neck aching and really sore. Seen on 4/1/02 and 4/2/02.
I did not have an adverse reaction to the vaccine. I started feeling symptoms on 08/24/2022 of a mild headache, stuffiness and tired. On 08/26/2022, I tested positive with a home test for COVID-19. I contacted my Pulmonologist and was given the prescription for PAXLOVID. I felt better but I did rebound and was sick for another week.
have contracted Covid. I am vaccinated with Pfizer; have contracted Covid. I am vaccinated with Pfizer; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "have contracted Covid. I am vaccinated with Pfizer". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Clinical course: Patient currently a nurse that works in the Health Department. Patient was prescribed Paxlovid but patient not able to get it filled due to lack of supply. Patient have contacted pharmacies but they are not willing to give information if they have it in stock. Patient's risk of being hospitalized and not making it are pretty high.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information currently available, The casual association between the reported events and suspected vaccine BNT162B2 cannot be completely excluded.
Received Pfizer COVID vaccines on 3/5/2021 and 3/26/2021 Hospitalized on 9/23/2021 with positive COVID 19 and Rhabdomyolitis Booster Pfizer vaccine received on 1/8/2022
Sore at the injection site; Malaise; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 70-year-old male patient who received HAB (Twinrix) (batch number H4A37, expiry date 18th October 2021) for prophylaxis.   Previously administered products included Twinrix with an associated reaction of injection site pain (1st dose received on 29th October 2019, batch number H4A37, expiry date 18 October 2021 refer case,US2020AMR076065).   On 3rd December 2019, the patient received the 2nd dose of Twinrix. On an unknown date, less than 6 months after receiving Twinrix, the patient experienced injection site pain and malaise. Rechallenge with Twinrix was positive. On an unknown date, the outcome of the injection site pain and malaise were unknown.   It was unknown if the reporter considered the injection site pain and malaise to be related to Twinrix.  Additional details were reported as follows: The pharmacist reported that a patient who does not want to receive the third dose of Twinrix at the recommended period because of the Covid-19 situation and because after the two first doses experienced malaise and sore at the injection site The reporter consented to follow up.  Third dose not coded as suspect because of medical reason event occur after two doses.
I am still having symptoms. It started with severe fatigue and sleeping 16 hours or more. As of 09/25/2015 I have had a headache, nausea and a terrible itch in my throat. Today I took allergy medicine because my throat was swollen. I can barely stay awake. Last year I broke out in hives for 10 days and my throat was swollen. I received a high dose of prednisone about 3 weeks after the flu shot. Was not 100% sure it was from the flu shot, but now I know it was.
tenderness and swelling in the areas where the filler was injected; tenderness and swelling in the areas where the filler was injected; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0150) via an unspecified route of administration in the arm left on 06Apr2021 at 08:15 (at the age of 33-year-old) as a dose 2, single for COVID-19 immunization. Medical history included dermal filler injection (had hyaluronic acid dermal fillers in my chin and along my jaw line approx. 1.5 years ago) and allergy to kiwi (fruit allergy). Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the arm left on 16Mar2021 at 18:30 (at the age of 33-year-old) as a dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 15:00, the patient experienced tenderness and swelling in the areas where the filler was injected. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event tenderness and swelling in the areas where the filler was injected was not recovered.  No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: 1. Country of Incidence and Event Occurred Country and Obtain Drug Country updated to US since not mentioned UNITED ARAB EMIRATES 2. Postal Code added in slide#1 reporter and patient tab.
Had stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), 5 months after the suspect product(s) administration, outcome "unknown", described as "Had stroke". Clinical course: 5 months after vaccine patient regret, patient had stroke.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300369357 same reporter/drug, different patient/event;
I have twin boys who were taken for 6 month vaccines. Honestly I am unsure about the accuracy of which companies I chose that manufactured them. I do know that my baby was perfectly fine until he was vaccinated and now I have a sick baby. He got a fever of 101.2, then the next day he started throwing up so bad he had to be taken to the ER and given zofran so that the poor little guy could hold down even a couple ounces of breast milk. Now he has diarrhea. Every doctor has discredited it being a reaction to the vaccine saying it must be a virus. Probably because they don't want to fill out additional paperwork. It's pretty obvious to me it's vaccine related. If it was a virus I am pretty sure his twin brother would have it as well.
Experienced intermittent, temporary loss of hearing ( seconds duration) in ears during  4/8 and 4/9 (approximately 3 times per ear)  Each ear was was affected individually, not simultaneously.  Subjectively, hearing seemed to recover, but hearing test has not been performed, yet . Since 4/9, have  persistent tinnitus in both ears.  Had telemedicine visit on 4/11 and will schedule evaluation with ENT specialist.
After receiving COVID injection patient tasted metal in mouth, and developed severe dry mouth.  Gave water and observed for 40 minutes.  Oxygen was 98-100%  HR 70-78 BP 146-150/96-100s.   Symptoms lasted around 1 hour.  After arriving home BP was 110/78.  Patient felt better.  No hospitalization needed.  Next day patient felt Body aches, Head ache, fever last 20 hours.  Patient feels better today 2/8/2020 the only symptom left is fatigue.
Injection site pain, tiredness, headache , muscle pain, chill, joint pain, nausea, feeling unwell, swollen lymph nodes, difficulty breathing, swelling of face, fast hearbeat, bad rash , dizziness and weakness, intestinal pain. All symptoms lasted 18 days. Was given prescription medication for symptoms by primary care doctor.
persistent swelling, tenderness, mild warmth left deltoid area after 9/23/07 not seen in office 5/30 prescribed PRN Tylenol, observation
Patient had redness and swelling on arm that went all the way down her arm and almost to her wrist.  She informed me of her symptoms on 12/9 and I told her to go to urgent care. She went to the doctors and was diagnosed with cellulitis. Saw her on 12/13 and she said her arm has improved significantly since she went on antibiotics (keflex).
At 4:42 shortness breath also became dizzy and nausea Sweating profusely that lasted about 20min. On the 19th had chest tightestness that radiated to arm. Hive and swollen lymph nodes swollen and visible.
Rotateq given at approximately 2:30 pm on Friday 08/18/2006.  Diarrhea began that same evening.  Liquid very foul smelling stools continued 5-7 per day since then.  Mom began offering Pedialyte Sunday and taking 2 and one half as tolerated. No fever.
Within 15 minutes vaccination I started to feel dizzy like everything was spinning. My blood pressure shot up to 160/100 and my heart rate was elevated over 100. In the afternoon I was really out of it and unable to drive. I was treated by the EMTS onsite. I went to the ER four days after I had another incident of the symptoms. I am consulting a Neurologist. I have had very severe headaches sine the day after the vaccine.  There is a feeling of pressure at the back of my head and sometimes like a band around my forehead. I am still having the headaches and the dizzy spells after nine weeks. Some days I have a milder headaches and they are coming and going. I have not gotten the second dose of the vaccine because I am fearful of the effects getting worse.
rash on her face, red dots that looked like freckles; petechiae and is spreading to her neck.; red rash on her face; red dots that looked like freckles; fatigue; nausea; throwing up; fever; experienced arm discomfort; This is a spontaneous report from a contactable other hcp (Nurse). This nurse (mother) reported for a 23-year-old female patient (daughter) that, A 23-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 09Aug2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 09Aug2021, the patient had arm discomfort (limb discomfort). On 10Aug2021, the patient developed fatigue, nausea, throwing up (vomiting), fever (pyrexia). On 11Aug2021, the patient had rash on her face, red dots that looked like freckles (rash), petechiae and is spreading to her neck (petechiae), red rash on her face (rash erythematous). Therapeutic measures were taken as a result of fatigue (fatigue), nausea (nausea), throwing up (vomiting), fever (pyrexia). The events fatigue, nausea, throwing up and fever that was resolved by taking Tylenol. The clinical outcome for the other events was Unknown.  Information about lot/batch has been requested.
This spontaneous report was received from a medical assistant concerning a 20 year old female patient. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 16-JUL-2018, the patient was vaccinated with PNEUMOVAX 23 lot # R002354 with expiration date of 17-DEC-2019, intramuscularly to prevent pneumococcal disease (dose, route of administration and anatomical location were not reported). On 19-JUL-2018, the patient developed pain and warmth at the site of PNEUMOVAX 23 injection; the patient also felt dizzy, had a headache and had difficulty raising the arm that had received the PNEUMOVAX 23 injection. On 20-JUL-2018, the patient also developed sweating and a fever of 101.6 Fahrenheit degrees. On the same date, the patient sought medical attention at the emergency room. It was unknown if the patient received any treatment for the adverse events. The outcome of injection site pain, pyrexia, hyperhidrosis, injected limb mobility decreased, headache, dizziness and injection site warmth was reported as not recovered. The causal relationship between the aforementioned events and therapy with vaccine, PNEUMOVAX 23 was not provided.
Information has been received from a registered nurse concerning an elderly patient (gender unknown) "usually in their 70's," who, on an unspecified date, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot#658555/0964U). Subsequently, the patient developed welts. The patient called the office. The patient was advised to use ice and TYLENOL if necessary. The patient recovered on unspecified dates. No product quality complaint was involved. This is one of five reports from the same source. Additional information has been requested.
6 weeks and 6 days pregnant, due September 2021.  I received 2nd dose of vaccine at 7:30 a.m.  and began feeling arm pain at injection site about 9:30 a.m.  At approximately 4:30 p.m.  I started to feel nauseas, have cold chills and body aches.  Those symptoms continued well into the early hours of the next morning, while dry heaving/vomiting 2x within that 12 hour period.  I continued to feel nauseas and have a headache well into the next day.  The majority of symptoms lasted 24 hours.  I drank water and diligently took Tylenol through that 24 hour period.
Unconsolable crying for 5 hours.  No fever or swelling on either leg.  Acting better on 05/15 @ 09:40 am.
Patient called to c/o sx - body aches, tiredness, puffy face. Seen that same day in Health Serivces. In no apparent distress, no local inflam. at inj. site. Face ? mildly puffy
Symptoms started day after vaccine and continued a whole week ended up in the Ed was diagnosed with adverse reaction to canid 19 vaccine. Symptoms were vomiting, nausea, diarrhea, headache, severe swelling in lower back, legs and arms, low oxygen levels, low grade fevers intermittent with shakes and hot and cold sweats.
Extreme chills & aching muscles - shoulders back and legs. Felt faint and light headed. Talked to Physician who encouraged me to take Benadryl (50mg).
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with the improperly stored doses of ROTATEQ orally, lot number: K019305, expiration date on 15-JUL-2016 (strength, dose number and anatomical location were not provided). No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
Severe tinnitus; Continued hair loss; severe muscle aches / fatigue symptoms associated with long Covid; Severe skin reaction; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Severe tinnitus), ALOPECIA (Continued hair loss), POST-ACUTE COVID-19 SYNDROME (severe muscle aches / fatigue symptoms associated with long Covid) and SKIN REACTION (Severe skin reaction) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Severe tinnitus), ALOPECIA (Continued hair loss), POST-ACUTE COVID-19 SYNDROME (severe muscle aches / fatigue symptoms associated with long Covid) and SKIN REACTION (Severe skin reaction). At the time of the report, TINNITUS (Severe tinnitus), ALOPECIA (Continued hair loss), POST-ACUTE COVID-19 SYNDROME (severe muscle aches / fatigue symptoms associated with long Covid) and SKIN REACTION (Severe skin reaction) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant product reported by reporter.  Suspect drug reported with unknown batch number and expiration date. Patient had severe muscle aches and fatigue as symptoms associated with long COVID.  No treatment medication reported by reporter.
This spontaneous report was received from a Nurse practitioner referring to a 36 year old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 09-FEB-2017, the patient was vaccinated with a dose of GARDASIL 9 intramuscularly, lot # M003659, expiration date on 20-SEP-2017 (strength, dose number and anatomical location were not provided) for Prophylaxis. The reported stated that no adverse event was reported. No product quality complain was involved.  Additional information is not expected, since no consent to contact the reporter was provided.
Patient received 2 vaccines around 2:40pm , after 2-3 hours she was shopping at store and felt like she was going to faint. She fainted at the register and the ambulance took her to the hospital. She informed us of this on Sunday and said her blood pressure was 77/___.  She couldn't remember the entire blood pressure. Per the patient, they gave her a bolus of saline. She told us the medical personnel thought she was dehydrated. She also informed us that she had only eaten 2 cookies that morning.
Pain at administration site on 10/6/15. On 10/7/15 (24 hrs later) pain and stiffness in left arm. Limited range of motion w/o pain, in left arm and shoulder continues.
Swelling red and hot raised area just below injection site. The affected area is hard to the touch.
pt devel 3 lesions on back of upper rt leg small scabs;no inc temp not ill;
Double vision.  Unable to focus eyes.  Seemed like it lasted a long time, but was probably about a minute.  Nothing like this has happened before.  Also had a blind spot later, around 8pm.  Looking at a person, they would look like a cyclops because I couldn't see their other eye.
Acute hepatic failure, question etiology, r/o relationship to recent Hepatitis A and Hepatits B vaccinations.
Patient was 37 weeks pregnant normal pregnancy 10/29: 1330-Patient received .25 ml MODERNA COVID19 booster dose at 1330.  1900- Patient was later induced at OBGYN's request for current diagnosis of Intrauterine growth restriction 2200- Patient received terbutaline at same, time patient's blood pressure rose and sustained with systolic in the 160's. Patient diagnosed with rapid onset of HELLP syndrome and severe preeclampisa 10/30:  0245- infant delivered at 37 weeks and 5 days. APGAR of 9 at time birth. MOC placed on antepartum care.  11/2 - both infant and mom discharged home